3B). Both patients showed absence of antibodies. No significant difference between 2 patients with multiple myeloma suffering from recurring pneumonia and other patients with myelomatosis was ...

Multiple myeloma (MM) is a life-threatening hematological ... This review will focus on MM antigens and their specific antibodies. These monoclonal antibodies are an attractive therapeutic tool ...

Multiple myeloma is ... help keep you healthy by making antibodies, proteins that fight infection. Sometimes, healthy plasma cells can become cancerous myeloma cells and multiply out of control.

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into optimising anti-CD38 antibody-containing quadruplet regimens (quads) for ...

1 Multiple myeloma originates in blood plasma cells — a type of cell found in bone marrow that is responsible for making antibodies. When these plasma cells become cancerous, they multiply ...

Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies. Multiple myeloma starts in the plasma ...

In this video, Sham Mailankody, MBBS discusses the current state of the pipeline for developing multiple myeloma treatments.

Bispecific antibodies remain a relatively new intervention for patients with multiple myeloma.They were not approved by the FDA until 2022, with teclistamab-cqyv (Tacvayl; Janssen Biotech, Inc ...

We're excited in the multiple myeloma that we continue to work in ... we have three ways of targeting this receptor, including the antibody direct conjugate, as well as the chimeric antigen ...